|1.||Lebeau, Annette: 2 articles (02/2009 - 05/2007)|
|2.||Holst, Frederik: 2 articles (02/2009 - 05/2007)|
|3.||Sauter, Guido: 2 articles (02/2009 - 05/2007)|
|4.||Simon, Ronald: 2 articles (02/2009 - 05/2007)|
|5.||Terracciano, Luigi: 2 articles (02/2009 - 05/2007)|
|6.||Wendroth, Scott M: 1 article (02/2015)|
|7.||Wick, Mark R: 1 article (02/2015)|
|8.||Mentrikoski, Mark J: 1 article (02/2015)|
|9.||Marie, Dierick Anne: 1 article (01/2014)|
|10.||Delgado, Juan Ramón: 1 article (01/2014)|
11/01/1982 - "Tumor involvement of the lymphatic vessels within the breast and estrogen receptor protein positivity or negativity were not helpful for identifying a subpopulation at increased risk of recurrence. "
02/01/2015 - "All 4 GATA3-negative tumors were Nottingham grade III lesions that were also nonreactive for estrogen receptor protein. "
10/01/2009 - "Brain sections, taken at various time points in tumor progression, were analyzed for estrogen receptor protein, proliferative index and apoptotic index. "
05/01/2007 - "Ninety-nine percent of tumors with ESR1 amplification showed estrogen receptor protein overexpression, compared with 66.6% cancers without ESR1 amplification (P < 0.0001). "
11/01/2005 - "The tumor cells did not express immunocytologic reactivity to estrogen receptor protein. "
03/01/2005 - "Estrogen receptor protein, PR, GCDFP, CK5/6, CK20, MUC5AC, MUC6, DAS-1, and CDX2 are helpful in distinguishing primary gastric carcinomas from metastatic breast carcinomas. "
11/01/1977 - "The study was undertaken to investigate the relationship between Barr body distribution and estrogen receptor protein content of mammary carcinoma. "
05/01/1995 - "Our purpose was to analyze the sensitivity, specificity, and positive predictive value of gross cystic disease fluid protein-15 (GCDFP-15) and estrogen receptor protein (ERP) for diagnosing cutaneous metastatic breast carcinoma. "
05/01/1995 - "Diagnostic immunohistochemistry of cutaneous metastatic breast carcinoma: a statistical analysis of the utility of gross cystic disease fluid protein-15 and estrogen receptor protein."
07/01/1987 - "Correlation of estrogen receptor protein and histopathologic characteristics in 175 cases of breast carcinoma."
|4.||Breast Neoplasms (Breast Cancer)
01/01/2014 - "Study assessing the quality of quantification of estrogen receptor protein expression by immunohistochemistry and gene expression in breast cancer."
07/01/1986 - "This study examined the factors influencing estrogen receptor protein levels in a population-based group of 168 incident cases of breast cancer in Olmsted County, Minnesota. "
02/21/2000 - "The distribution of estrogen receptor protein-alpha (ER-alpha)-containing cells in the human hypothalamus and adjacent regions was studied using a monoclonal antibody (H222) raised against ER-alpha derived from MCF-7 human breast cancer cells. "
08/01/1994 - "Estrogen receptor protein levels were determined for 171 patients with primary breast cancer either by radio-ligand binding assay (ER-LBA) or enzyme immunoassay (ER-EIA). "
07/01/1994 - "EGFR could be measured in most breast tumors, and the level of its expression has inversely correlated with estrogen receptor protein expression. "
04/01/1979 - "Estrogen-receptor protein in intracranial meningiomas."
09/01/1987 - "Low levels of estrophilin immunoreactivity were found in tumors from 62% of patients, whereas radioligand binding activity was demonstrated in about 46% of the meningiomas examined. "
04/01/1979 - "Because the epidemiology and clinical course of some meningiomas suggest that these tumors may be hormonally sensitive and that they may contain estrogen receptor protein, and because two-thirds of all intracranial meningiomas and 80% of all spinal meningiomas occur in women, the relationship between pregnancy (and its hormonal alterations) and development of these meningiomas was studied using tissue samples obtained from 6 patients with meningiomas. "
04/01/1979 - "Tumor tissue from six patients with meningiomas was analyzed for estrogen-receptor protein. "
09/01/1987 - "Estrophilin immunoreactivity versus estrogen receptor binding activity in meningiomas: evidence for multiple estrogen binding sites."
|4.||Complementary DNA (cDNA)
|5.||Indicators and Reagents (Reagents)